Stocktoria
Amplifon S.p.A. AMP.MI
IT · Borsa Italiana · XMIL · stock · Healthcare · website
Amplifon S.p.A. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €2.4B | €2.4B | €2.3B | €2.1B |
| Gross profit | €1.3B | €1.4B | €1.3B | €1.2B |
| Operating income | €204.8M | €253.3M | €250.6M | €267.2M |
| Interest expense | €59.7M | €57.8M | €44.6M | €30.7M |
| Income tax | €40.2M | €51.2M | €54.7M | €65.0M |
| Net income | €91.3M | €145.4M | €155.1M | €178.5M |
| EPS (diluted) | €0.42 | €0.65 | €0.69 | €0.79 |
| Operating cash flow | €414.8M | €451.2M | €413.5M | €458.6M |
| Free cash flow | €296.4M | €304.7M | €271.9M | €343.0M |
| Cash & equivalents | €308.9M | €288.8M | €193.1M | €179.7M |
| Inventory | €82.5M | €93.2M | €88.3M | €76.3M |
| Goodwill | €1.9B | €1.9B | €1.8B | €1.8B |
| Total assets | €3.9B | €4.0B | €3.7B | €3.6B |
| Total debt | €1.8B | €1.7B | €1.5B | €1.5B |
| Total liabilities | €2.9B | €2.8B | €2.6B | €2.5B |
| Shareholders' equity | €998.2M | €1.2B | €1.1B | €1.0B |
| Share buybacks | €108.3M | €25.5M | €215,000 | €53.7M |
Growth · year-over-year · Revenue CAGR 4.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -0.6% | +6.6% | +6.7% | — |
| Net income growth | -37.2% | -6.3% | -13.1% | — |
| EPS growth | -35.6% | -6.1% | -12.7% | — |
| Free cash flow growth | -2.7% | +12.1% | -20.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · IT · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.